Citation Impact
Citing Papers
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
2018
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD)
2015
Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain
2016
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Arynes and Cyclohexyne in Natural Product Synthesis
2012 Standout
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Monofunctionalized Pillar[5]arene as a Host for Alkanediamines
2011 StandoutNobel
Psychedelic-inspired drug discovery using an engineered biosensor
2021
Differential phospholipase C activation by phenylalkylamine serotonin 5‐HT2Areceptor agonists
2005
Functional implications of decreases in neurogenesis following chronic mild stress in mice
2007
The effects of chronic mild stress on male Sprague–Dawley and Long Evans rats
2002
CH Bond Functionalization: Emerging Synthetic Tools for Natural Products and Pharmaceuticals
2012 Standout
Mechanized Silica Nanoparticles Based on Pillar[5]arenes for On‐Command Cargo Release
2013 StandoutNobel
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Serotonin, But Not N -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo
2010
Predicting new molecular targets for known drugs
2009 Nature
Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (“FLY”) and benzodifuran (“DragonFLY”) analogs
2018
Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation
1997 Standout
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
2007 StandoutNobel
ChEMBL: a large-scale bioactivity database for drug discovery
2011 Standout
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
2016
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Psychedelics
2016 Standout
Psychedelics Promote Structural and Functional Neural Plasticity
2018
Network medicine: a network-based approach to human disease
2010 Standout
Palladium(II)‐Catalyzed CH Activation/CC Cross‐Coupling Reactions: Versatility and Practicality
2009 Standout
Proteins with β‐(thienopyrrolyl)alanines as alternative chromophores and pharmaceutically active amino acids
2001 Nobel
Recent advances in transition-metal-free carbon–carbon and carbon–heteroatom bond-forming reactions using arynes
2012 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
2021
Behavioral and biochemical studies on chronic mild stress models in rats treated with a Chinese traditional prescription Banxia-houpu decoction
2003
Diurnal Variation in the Effect of Chronic Mild Stress on Sucrose Intake and Preference
1997
Dynamic self-inclusion behavior of pillar[5]arene-based pseudo[1]rotaxanes
2013
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
2003
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
A self-complexing and self-assembling pillar[5]arene
2011 StandoutNobel
Drug repurposing: progress, challenges and recommendations
2018 Standout
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
The elevated T-maze as an experimental model of anxiety
1998
Asararenes—A Family of Large Aromatic Macrocycles
2013 StandoutNobel
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
2017
Microwave assisted Leimgruber–Batcho reaction for the preparation of indoles, azaindoles and pyrroylquinolines
2004
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
2020
The neural basis of psychedelic action
2022 Standout
Dynamic clicked surfaces based on functionalised pillar[5]arene
2011 StandoutNobel
Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior
2007
Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors
2007
Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences
2000
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
Controlled Microwave Heating in Modern Organic Synthesis
2004 Standout
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
2019
β-arrestin-mediated receptor trafficking and signal transduction
2011 StandoutNobel
Enantiopure pillar[5]arene active domains within a homochiral metal–organic framework
2014 StandoutNobel
Incorporation of an A1/A2-Difunctionalized Pillar[5]arene into a Metal–Organic Framework
2012 StandoutNobel
Synthesis of Heterocycles via Electrophilic Cyclization of Alkynes Containing Heteroatom
2011 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Stereoselective Construction of Highly Functionalized Azetidines via a [2 + 2]-Cycloaddition
2010
Pillar[5]arene as a Co-Factor in Templating Rotaxane Formation
2013 StandoutNobel
C-H Bond Functionalization in Complex Organic Synthesis
2006 StandoutScience
Ex2Box: Interdependent Modes of Binding in a Two-Nanometer-Long Synthetic Receptor
2013 StandoutNobel
Strong and Confined Acids Catalyze Asymmetric Intramolecular Hydroarylations of Unactivated Olefins with Indoles
2021 StandoutNobel
Synthesis of Tricyclic Heterocycles via a Tandem Aryl Alkylation/Heck Coupling Sequence
2006
Porphyrinic supramolecular daisy chains incorporating pillar[5]arene–viologen host–guest interactions
2015 StandoutNobel
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure–Activity Relationship Studies
2020
Cyclometalated Phosphine-Based Pincer Complexes: Mechanistic Insight in Catalysis, Coordination, and Bond Activation
2003 Standout
Enantioselective Total Synthesis of (−)-Citrinadin A and Revision of Its Stereochemical Structure
2013
Functionalizing Pillar[n]arenes
2014 StandoutNobel
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
2021
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Carboxylate-Assisted Transition-Metal-Catalyzed C−H Bond Functionalizations: Mechanism and Scope
2011 Standout
Electrophilic Cyclization of 2-Chalcogenealkynylanisoles: Versatile Access to 2-Chalcogen-benzo[b]furans
2009
Annulation of Aromatic Imines via Directed C−H Bond Activation
2005
Synthesis of Novel (Phenylalkyl)amines for the Investigation of StructureActivity Relationships, Part 3
2003
Investigation of the Structure–Activity Relationships of Psilocybin Analogues
2020
Psychedelic-Inspired Drug Discovery Using an Engineered Biosensor
2020
Spin‐Labelled Pillar[5]arene as Paramagnetic Host for Supramolecular Assemblies
2013
Effective connectivity changes in LSD-induced altered states of consciousness in humans
2019
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex
2003
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
Synthesis of a Tricyclic Mescaline Analogue by Catalytic C−H Bond Activation
2003
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
2020
Transition-Metal-Catalyzed Reactions in Heterocyclic Synthesis
2004 Standout
Stereochemically controlled syntheses of indole-substituted dihydrofuran-2-ones and a pyrrolidin-2-one
2000
Transition Metal-Catalyzed C–H Amination: Scope, Mechanism, and Applications
2017 Standout
Formation of η2 C−H Agostic Rhodium Arene Complexes and Their Relevance to Electrophilic Bond Activation
1998
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
2008
Rhodium-Catalyzed C−C Bond Formation via Heteroatom-Directed C−H Bond Activation
2009 Standout
Redox Control of the Binding Modes of an Organic Receptor
2015 StandoutNobel
Gold(I)-Catalyzed Activation of Alkynes for the Construction of Molecular Complexity
2015 Standout
Hallucinogens
2004 Standout
Indole-Derived Arynes and Their Diels−Alder Reactivity with Furans
2007
Works of Danuta Marona‐Lewicka being referenced
Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives
1994
Lysergamides Revisited
1994
WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation
2009
Potential serotonin 5-HT1A and dopamine D4 receptor modulation of the discriminative stimulus effects of amphetamine in rats
2011
An animal model of schizophrenia based on chronic LSD administration: Old idea, new results
2011
Stereoselective LSD-like Activity in a Series of d-Lysergic Acid Amides of (R)- and (S)-2-Aminoalkanes
1995
Complex stimulus properties of LSD: a drug discrimination study with α2-adrenoceptor agonists and antagonists
1995
Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine 1A receptor-mediated behavioral effects overlap its other properties in rats
2002
Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
2014
Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent
1995
A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties
2001
Reinforcing effects of certain serotonin-releasing amphetamine derivatives
1996
5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat
1997
Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI
2008
Aripiprazole (OPC-14597) fully substitutes for the 5-HT 1A receptor agonist LY293284 in the drug discrimination assay in rats
2004
Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action
2007
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis
2005
‘Hybrid’ benzofuran–benzopyran congeners as rigid analogs of hallucinogenic phenethylamines
2008
1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: A Potent Serotonin 5-HT2A/2C Agonist
1994
Lysergamides of Isomeric 2,4-Dimethylazetidines Map the Binding Orientation of the Diethylamide Moiety in the Potent Hallucinogenic Agent N,N-Diethyllysergamide (LSD)
2002
1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2AReceptor Agonists
2006
The Effect of Selective Serotonin Releasing Agents in the Chronic Mild Stress Model of Depression in Rats
1997
Extensive Rigid Analogue Design Maps the Binding Conformation of Potent N-Benzylphenethylamine 5-HT2A Serotonin Receptor Agonist Ligands
2012
Substituted Naphthofurans as Hallucinogenic Phenethylamine−Ergoline Hybrid Molecules with Unexpected Muscarinic Antagonist Activity
1998
Novel serotonergic agents.
1993
Thieno[3,2-b]- and Thieno[2,3-b]pyrrole Bioisosteric Analogues of the Hallucinogen and Serotonin Agonist N,N-Dimethyltryptamine
1999
Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives
1997
A Novel (Benzodifuranyl)aminoalkane with Extremely Potent Activity at the 5-HT2A Receptor
1998
Synthesis and Pharmacological Characterization of a Series of Geometrically Constrained 5-HT2A/2C Receptor Ligands
2003
Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups
1996
Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines
2000
Further Studies on Oxygenated Tryptamines with LSD-like Activity Incorporating a Chiral Pyrrolidine Moiety into the Side Chain
1999
C-(4,5,6-Trimethoxyindan-1-yl)methanamine: A Mescaline Analogue Designed Using a Homology Model of the 5-HT2AReceptor
2006